For mild-to-moderate inflamed jawline acne, azelaic acid performs about as well as benzoyl peroxide — a single-blind randomized trial of 351 patients found azelaic acid 15% gel cut papules and pustules by a median 70% against 71% for 5% benzoyl peroxide gel, an equivalence indexed on PubMed, with noticeably less burning and irritation. Where they part company is the strength of the evidence behind them, not the result in that trial. Azelaic acid is a dicarboxylic acid that kills acne bacteria, calms inflammation and slows the pigment-producing enzyme tyrosinase. The 2024 American Academy of Dermatology acne guideline gives benzoyl peroxide a **strong** recommendation and topical azelaic acid only a **conditional** one, in its acne guideline — both are endorsed, but azelaic acid rests on a thinner evidence base.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the head-to-head numbers actually show
- Where azelaic acid stops working
- The pigmentation warning that matters most on the jaw
- When azelaic acid is the clear choice over benzoyl peroxide
- What the UK guideline does differently
- The benzene recalls, in proportion
- Frequently Asked Questions
What the head-to-head numbers actually show
The 70%-versus-71% result is the closest thing to a direct answer. A one-point gap between two medians in a 351-patient trial is noise, not a winner. For inflamed lesions — the tender red bumps that cluster along the jaw — the two drugs did the same job. Tolerability was the real difference.
Azelaic acid produced distinctly less local burning and stinging than the benzoyl peroxide gel. On the jawline that matters more than it sounds, because the skin there gets rubbed by collars, phones and razors, and an irritating product in that zone tends to be abandoned. Azelaic acid's track record is not limited to one comparison. A European overview of 20% azelaic acid cream concluded it works as monotherapy in mild-to-moderate acne with efficacy comparable to tretinoin 0.05%, benzoyl peroxide 5% and topical erythromycin 2%, in a 1996 review, alongside a favorable side-effect profile.
Where azelaic acid stops working
The FDA-approved label for Azelex (azelaic acid 20% cream) limits the indication to mild-to-moderate **inflammatory** acne vulgaris. Two words in that phrase set the boundary. "Mild-to-moderate" rules out severe disease — deep nodules and cysts along the jaw and neck are not what this drug was approved to treat.
"Inflammatory" rules out purely comedonal acne: if your jawline shows closed whiteheads and blackheads rather than red papules, azelaic acid monotherapy is the wrong tool. The label specifies twice-daily application with improvement in most patients within about four weeks. Four weeks is the number to hold yourself to. If the jawline looks the same at the one-month mark on consistent twice-daily use, the answer is to change the plan, not to keep waiting.
The pigmentation warning that matters most on the jaw
Jawline acne leaves marks. Post-inflammatory hyperpigmentation along the mandible is often what sends people looking for azelaic acid in the first place, since it inhibits tyrosinase and fades dark spots as well as treating the lesion. That same strength carries the drug's main caution.
The FDA label warns of isolated reports of hypopigmentation — patches lighter than surrounding skin — and advises monitoring patients with dark complexions for early signs, because azelaic acid has not been well studied in that group. The warning appears in the 2024 Azelex label. Practically, if your skin tone is deep and you are treating jawline marks, check the treated area in daylight every few weeks and compare it with untreated skin. Any patch going lighter rather than darker is a reason to stop and talk to a clinician.
When azelaic acid is the clear choice over benzoyl peroxide
Pregnancy is the strongest case. A narrative review in *Dermatology and Therapy* reports azelaic acid is considered safe in all trimesters with no adverse fetal effects reported, while topical retinoids and spironolactone — the usual drugs for hormonal jawline acne — are contraindicated, as that 2022 review sets out.
That removes the two most common jawline treatments and leaves azelaic acid standing. Other situations that favor it:.
- Sensitive or easily irritated skin, given the lower burning rate in the head-to-head trial
- Jawline acne accompanied by dark post-acne marks, where the tyrosinase effect does double duty
- Fabric and hair you do not want bleached, since benzoyl peroxide lifts color from towels, pillowcases and collars
- A preference to avoid a retinoid or an oral antibiotic
What the UK guideline does differently
NICE guideline NG198 reads the two drugs almost in reverse. It places azelaic acid in first-line therapy only **in combination** with oral lymecycline or doxycycline, for moderate-to-severe acne, and demotes benzoyl peroxide monotherapy to an alternative when first-line combinations are contraindicated or the patient wants to avoid a retinoid or antibiotic. The recommendations are set out in NG198, updated July 2023. The disagreement with the AAD is less about efficacy than about role.
NICE treats azelaic acid as a partner to an oral antibiotic in more serious disease; the AAD's conditional nod reflects weaker trial evidence for it used alone. Neither body suggests it is useless, and neither treats it as a first choice by itself. That has a bearing on jawline acne specifically, which often gets labelled hormonal and treated as a special case. Dréno and colleagues' observational study of 374 adult women found acne confined to the mandibular area in only 11.2%, while 89.8% had multiple facial zones involved — and lower-face location by itself did not predict hyperandrogenism, in their 2015 JEADV paper. Most "jawline acne" is ordinary facial acne that happens to be noticed there, which is why ordinary acne treatment applies.
The benzene recalls, in proportion
If benzoyl peroxide is the comparator, the 2025 contamination story deserves a straight accounting rather than a scare. FDA testing of 95 benzoyl peroxide acne products, announced March 11, 2025, found more than 90% had undetectable or extremely low benzene.
Six products were recalled at retail level for elevated benzene, including La Roche-Posay Effaclar Duo and two Proactiv items, as reported on the FDA announcement. The FDA stated the cancer risk is very low even with decades of daily use. That is not a reason to switch to azelaic acid; the better move is to check whether your specific product was among the six recalled and store it as the label directs rather than in a hot bathroom.
Frequently Asked Questions
Can I use azelaic acid and benzoyl peroxide together on my jawline?
Nothing in the evidence here tests that pairing. Given that benzoyl peroxide caused distinctly more burning on its own, stacking two actives on jawline skin that collars and razors already irritate invites more irritation than either alone. Ask a clinician before combining them.
How long before I know azelaic acid is working?
The Azelex label reports improvement in most patients within about four weeks of twice-daily use. Treat four consistent weeks as your decision point.
Does azelaic acid help blackheads along the jawline?
Its FDA indication covers mild-to-moderate *inflammatory* acne — the red papules and pustules. Purely comedonal jawline congestion falls outside what the label supports.
My jawline acne is the only place I break out. Does that mean it is hormonal?
Not on location alone. Dréno and colleagues found lower-face location by itself did not predict hyperandrogenism, and only 11.2% of the 374 women studied had acne confined to the jawline at all.